EGFR and lung carcinoma: Non-small cell lung cancer, EGFR, targeted therapy, lung cancer, EGFR-TKI, erlotinib, chemotherapy, cancer, sunitinib, and resistance all appear in the top 10 list of degree centralization and closeness centralization.